Recent Analyst Forecasts and Stock Ratings
Definium Therapeutics Inc. FAQ's
Definium Therapeutics Inc. has been rated by research analysts at Needham, Canaccord Genuity, Oppenheimer, Leerink Partners, Piper Sandler, Stifel Nicolaus in the past 90 days.